Sameer Gupta, MD
MOHS-Micrographic Surgery · Boston, MANPI 1851741268
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $7,500 of the $11,325 with a category attached, or 66.2%. Sun Pharmaceutical Industries Inc. accounts for 81.2% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $11,201, more than ten times the $29 reported in 2022. Among mohs-micrographic surgery clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 14 payments — averaging $808.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$9K
- ARS Pharmaceuticals Operations, Inc.$2K
- Dermavant Sciences, Inc.$70
- AbbVie$29
- Abiomed$25
What the payments were for
- Consulting fees$7,50066%
- Speaking & faculty fees$2,00018%
- Travel & lodging$1,32012%
- Food & beverage$5054%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 10 | $9,201 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $2,000 |
| Dermavant Sciences, Inc. | 1 | $70 |
| AbbVie | 1 | $29 |
| Abiomed | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,325 in reported general payments places this provider in the 90th percentile of 38 mohs-micrographic surgery providers in Massachusetts.
See all mohs-micrographic surgery providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErivedgeVismodegib | 24 | $300,467 |
| OdomzoSonidegib Phosphate | 13 | $161,922 |
| Fluorouracil | 15 | $646 |
| Doxycycline Monohydrate | 112 | $556 |
| Cephalexin | 14 | $38 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Boston
- Benjamin SolkyBoston$7K
- Jonathan WeissBoston$3K
- Paul MasseyBoston$1K
- Anna SutherlandBoston$657
- Katayun AdhamiBoston$560
- Ramone WilliamsBoston$200
- Nina RanBoston$121
- Patricia RicheyBoston$47
- Chrysalyne SchmultsJamaica Plain$58K
- Suzanne OlbrichtBurlington$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.